DRD2 and glioblastoma: Our results showed that PMVS‐P neurotransmitter‐mimicking nanovesicle promoted endocytosis of GSCs through PDA‐mediated D2DR identification, thus exacerbating the toxicity of GSCs and inhibiting GBM recurrence.